3-D Matrix, Ltd.

Tokyo Stock Exchange 7777.T

3-D Matrix, Ltd. Shares (Diluted, Weighted) for the year ending April 30, 2024: 73,288,046

3-D Matrix, Ltd. Shares (Diluted, Weighted) is 73,288,046 for the year ending April 30, 2024, a 21.76% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

3-D Matrix, Ltd. Shares (Diluted, Weighted) for the year ending April 30, 2023 was 60,191,333, a 18.18% change year over year.
3-D Matrix, Ltd. Shares (Diluted, Weighted) for the year ending April 30, 2022 was 50,933,291, a 25.66% change year over year.
3-D Matrix, Ltd. Shares (Diluted, Weighted) for the year ending April 30, 2021 was 40,533,704, a 35.32% change year over year.
3-D Matrix, Ltd. Shares (Diluted, Weighted) for the year ending April 30, 2020 was 29,954,332, a 14.22% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Tokyo Stock Exchange: 7777.T

3-D Matrix, Ltd.

CEO	Mr. Jun Okada
IPO Date	Oct. 24, 2011
Location	Japan
Headquarters	Kojimachi HF Building
Employees	106
Sector	Health Care
Industries Biotechnology 3D Printing Chemicals & Advanced Materials Pharmaceuticals

Description

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.

Key trends

Past 5 years